Author

Kerstin Heurling

Observed names: Heurling, K., Heurling, Kerstin, K. Heurling, KERSTIN HEURLING

Observed institutions: Uppsala University, Uppsala University Hospital, Lund University, Sahlgrenska University Hospital, Antaros Medical (Sweden), Skåne University Hospital, Wallenberg Centre for Molecular and Translational Medicine, Medical University of Vienna, University of Gothenburg

ORCID: 0000-0001-8497-9612

Observed ORCID: 0000-0001-8497-9612

OpenAlex ID: A5036649129

Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial

2019 · Fredrik Rosqvist, Joel Kullberg, et al. · The Journal of Clinical Endocrinology & Metabolism · 251

[ 18 F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid‐β pathology

2015 · Dietmar Rudolf Thal, Thomas G. Beach, et al. · Alzheimer s & Dementia · 166

PDF

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

2016 · Milos D. Ikonomovic, Chris J. Buckley, et al. · Acta Neuropathologica Communications · 105

PDF

Synaptic vesicle protein 2A as a potential biomarker in synaptopathies

2019 · Kerstin Heurling, Nicholas J. Ashton, et al. · Molecular and Cellular Neuroscience · 79

PDF

Update on Biomarkers For Amyloid Pathology in Alzheimer’s Disease

2018 · Nicholas J Ashton, Michael Schöll, et al. · Biomarkers in Medicine · 79

PDF

Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

2018 · Gretha Boersma, Emil Johansson, et al. · Hormone and Metabolic Research · 65

Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study

2021 · Jonas Oldgren, Sanna Laurila, et al. · Diabetes Obesity and Metabolism · 64

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies

2019 · Fiona Heeman, Maqsood Yaqub, et al. · EJNMMI Research · 62

PDF

Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis

2015 · Kerstin Heurling, Antoine Leuzy, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 60

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

2018 · Dietmar Rudolf Thal, Thomas G. Beach, et al. · Acta Neuropathologica · 59

PDF

Quantitative positron emission tomography in brain research

2017 · Kerstin Heurling, Antoine Leuzy, et al. · Brain Research · 57

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia

2019 · Dietmar Rudolf Thal, Alicja Ronisz, et al. · Acta Neuropathologica Communications · 46

PDF

Positron emission tomography with [ 18 F]flutemetamol and [ 11 C] PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients

2013 · V. Leinonen, J. O. Rinne, et al. · European Journal of Neurology · 43

Whole-Body Imaging of Tissue-specific Insulin Sensitivity and Body Composition by Using an Integrated PET/MR System: A Feasibility Study

2017 · Emil Johansson, Mark Lubberink, et al. · Radiology · 42

Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder

2016 · Tomas Furmark, Ina Marteinsdottir, et al. · Journal of Psychopharmacology · 42

In vivo Detection of Alzheimer's Disease.

2018 · Antoine Leuzy, Kerstin Heurling, et al. · Europe PMC (PubMed Central) · 31

Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issues

2014 · Antoine Leuzy, Eduardo Rigon Zimmer, et al. · Amyloid · 31

Simulating the effect of cerebral blood flow changes on regional quantification of [ 18 F]flutemetamol and [ 18 F]florbetaben studies

2020 · Fiona Heeman, Maqsood Yaqub, et al. · Journal of Cerebral Blood Flow & Metabolism · 26

PDF

Parametric imaging and quantitative analysis of the PET amyloid ligand [ 18 F]flutemetamol

2015 · Kerstin Heurling, Chris Buckley, et al. · NeuroImage · 26

PDF

Correction to: Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia

2020 · Dietmar Rudolf Thal, Alicja Ronisz, et al. · Acta Neuropathologica Communications · 25

PDF

Diagnostic effectiveness of quantitative [18F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus

2014 · Ville Leinonen, Juha O Rinne, et al. · Acta Neuropathologica Communications · 24

PDF

O1‐01‐05: [18f]flutemetamol Amyloid Pet in Symptomatic Alzheimer's Disease (ad) and Pathologically Preclinical Ad (p‐pread) in Comparison to Non‐ad Controls: Impact of Cerebral Amyloid Angiopathy

2014 · Dietmar Thal, Thomas G. Beach, et al. · Alzheimer s & Dementia · 21

Lower 68Ga‐DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland—A proof‐of‐concept study

2019 · Axel Tjörnstrand, Olivera Casar‐Borota, et al. · Clinical Endocrinology · 19

Pre‐ and postoperative 68Ga‐DOTATOC positron emission tomography for hormone‐secreting pituitary neuroendocrine tumours

2021 · Axel Tjörnstrand, Olivera Casar‐Borota, et al. · Clinical Endocrinology · 15

PDF

Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

2018 · Gretha Boersma, Emil Johansson, et al. · Hormone and Metabolic Research · 15

Works count: 87

Citation count: 1,578

H-index: 21

I10-index: 30